早期血管性认知功能障碍生物标志物的研究进展(7)
[51] Jia JP， Meng R， Sun YX， et al. Cerebrospinal fluid tau， Aβ1-42 and inflammatory cytokines in patients with Alzheimer’s disease and vascular dementia [J]. Neurosci Lett， 2005， 383(1-2)： 12-16.
[52] Stefani A， Bernardini S， Panella M， et al. AD with subcortical white matter lesions and vascular dementia： CSF markers for differential diagnosis [J]. J Neurol Sci， 2005， 237(1-2)： 83-88.
[53] Paraskevas GP， Kapaki E， Papageorgiou SG， et al. CSF biomarker profile and diagnostic value in vascular dementia[J]. Eur J Neurol， 2009， 16(2)： 205-211.
[54] Cavedo E， Lista S， Khachaturian Z， et al. The road ahead to cure Alzheimer’s disease： development of biological markers and neuroimaging methods for prevention trials across all stages and target populations [J]. J Prev Alzheimers Dis， 2014， 1(3)： 181-202.
[55] Tato RE， Frank A， Hernanz A. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type [J]. J Neurol Neurosurg Psychiatry， 1995， 59(3)： 280-283.
[56] Andreasen N， Vanmechelen E， Van de Voorde A， et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease： a community based follow up study [J]. J Neurol Neurosurg Psychiatry， 1998， 64(3)： 298-305., http://www.100md.com(毛蕾 付饶 马天君 尹又)
[52] Stefani A， Bernardini S， Panella M， et al. AD with subcortical white matter lesions and vascular dementia： CSF markers for differential diagnosis [J]. J Neurol Sci， 2005， 237(1-2)： 83-88.
[53] Paraskevas GP， Kapaki E， Papageorgiou SG， et al. CSF biomarker profile and diagnostic value in vascular dementia[J]. Eur J Neurol， 2009， 16(2)： 205-211.
[54] Cavedo E， Lista S， Khachaturian Z， et al. The road ahead to cure Alzheimer’s disease： development of biological markers and neuroimaging methods for prevention trials across all stages and target populations [J]. J Prev Alzheimers Dis， 2014， 1(3)： 181-202.
[55] Tato RE， Frank A， Hernanz A. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type [J]. J Neurol Neurosurg Psychiatry， 1995， 59(3)： 280-283.
[56] Andreasen N， Vanmechelen E， Van de Voorde A， et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease： a community based follow up study [J]. J Neurol Neurosurg Psychiatry， 1998， 64(3)： 298-305., http://www.100md.com(毛蕾 付饶 马天君 尹又)